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Abstract
Background: With over 1 million HIV-related deaths annually, quality end-of-life care remains a priority. Given strong
public preference for home death, place of death is an important consideration for quality care. This 11 country study
aimed to i) describe the number, proportion of all deaths, and demographics of HIV-related deaths; ii) identify place of
death; iii) compare place of death to cancer patients iv), determine patient/health system factors associated with place
of HIV-related death.
Methods: In this retrospective analysis of death certification, data were extracted for the full population (ICD-10 codes
B20-B24) for 1-year period: deceased’s demographic characteristics, place of death, healthcare supply.
Results: i) 19,739 deaths were attributed to HIV. The highest proportion (per 1000 deaths) was for Mexico (9.8‰), and
the lowest Sweden (0.2‰). The majority of deaths were among men (75%), and those aged <50 (69.1%). ii) Hospital
was most common place of death in all countries: from 56.6% in the Netherlands to 90.9% in South Korea. The least
common places were hospice facility (3.3%–5.7%), nursing home (0%–17.6%) and home (5.9%–26.3%).iii) Age-
standardised relative risks found those with HIV less likely to die at home and more likely to die in hospital
compared with cancer patients, and in most countries more likely to die in a nursing home. iv) Multivariate
analysis found that men were more likely to die at home in UK, Canada, USA and Mexico; a greater number
of hospital beds reduced the likelihood of dying at home in Italy and Mexico; a higher number of GPs was
associated with home death in Italy and Mexico.
Conclusions: With increasing comorbidity among people ageing with HIV, it is essential that end-of-life preferences
are established and met. Differences in place of death according to country and diagnosis demonstrate the importance
of ensuring a “good death” for people with HIV, alongside efforts to optimise treatment.
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Background
Despite the increasing availability of ART since 1996 [1]
people still continue to die as a result of HIV infection
[2]. This may be due to late presentation, limited access
to treatment, suboptimal adherence, or HIV-related
comorbidities and complications from long term infec-
tion and treatment, all of which require high quality
HIV care through to the end of life [3]. Arguably, the
advent of ART has led to a loss of focus on the end-of-
life care needs of people living with HIV [4]. This gap is
particularly concerning given clear evidence of continu-
ing need for palliative and end-of-life care [5], and
UNAIDS data estimating 1.2 million HIV-related deaths
in 2014 [6].
The HIV epidemic is a challenge to health systems [7].
Even in high income countries with universal ART access,
death rates among persons diagnosed with HIV infection
remain high compared with the general population [8].
Place of death is a prime consideration for all people
with serious illness. The clinical relevance lies in the
potential for the patient to select place of death, thereby
relieving concerns about the unknown process of dying,
reduce anxieties about the future, enhance quality of life
and the quality of death [9]. In European countries, the
public express a strong preference to die at home [10],
whereas evidence suggests that in low income countries
the preference is for hospital death [11, 12]. This latter
preference may reflect the variability of palliative and
end-of-life care services to enable people to die at home
[13], or reflect the lack of personal resources to deliver
care in the home compared to hospital resources. It may
also reflect the stigma associated with HIV [14], which
may lead to social ostracisation and lack of support for
home-based care.
Understanding where people die with HIV is import-
ant from a policy and funding perspective, as it indicates
where resources and skills are needed to help patients
and their families at the end of life. From a public health
perspective, it is important to ensure well organized,
high quality end-of-life care [15]. Place of death among
people with HIV has not been studied since a single city
Scottish study in 1995 [16]. Our cross-national study in
11 countries from three continents had the following
objectives: i) to describe the number of HIV-related
deaths, these as a proportion of all deaths, and demo-
graphics of the deceased; ii) identify place of death; iii)
compare place of HIV-related death to those who died
from cancer; iv), determine patient and health system
factors associated with place of HIV-related death.
Methods
Study design
This study is part of the International Place of Death
(iPoD) study, collecting death certificate data for the full
population of deaths for a period of 1 year in 15 coun-
tries. Initial scoping of available data was conducted to
ensure similarity of the variables. Data were obtained
from 15 countries for the year 2008, except for the USA
where 2007 was used as it was the most recent full
available year, and partial data were obtained for Spain
as Andalusia did not record place of death before
2010. All data were pooled into one common data-
base for analysis.
Previous analyses from the iPoD study have reported
place of death for cancer and non-cancer conditions
[17–20], but have not reported HIV-related place of
death. In addition to place of death data, we set out to
obtain a number of clinical, sociodemographic and
residential characteristics of the deceased, based on
factors that have been identified as associated with the
place of death [21].
Participating countries
We conducted this analysis on countries with ART
coverage of at least 80% for those eligible [22], and with
known provision of palliative care according to the
World Health Organisation’s global analysis [23]. The
included countries were as follows: Canada, France, Italy,
Belgium, UK, Sweden, USA (all categorized as having the
highest palliative care provision ranking of “advanced inte-
gration into mainstream service provision”); Spain and the
Netherlands (ranked by the WHO as having “preliminary
integration”); and Mexico and South Korea (ranked as
having “isolated provision”). Three countries were
excluded in this analysis because of small numbers (i.e.
<10 reported HIV-related deaths: Czech Republic,
Hungary and New Zealand, see Table 1 below). A total of
11 countries (combining England and Wales) were
included in the analyses.
Data sources
All included countries have similar death certification:
an attending official certifies the sex of the deceased,
diagnostic information and one or more primary and
secondary causes of death, the day, and place of death.
The respective authorities in each country check these
certificates for inconsistencies and code the causes of
death according to the WHO’s International Classifica-
tion of Diseases 10th Revision (ICD-10) classification
system of diseases [24]. All deaths with HIV/AIDS as
an underlying cause of death (ICD-10 codes B20-B24)
were selected.
Some death certificates contain additional socio-
demographic information for the deceased, information
often supplied by a civil servant of the civil registrar of
the municipality of death; for other countries this infor-
mation is not available through death certificates but
unique linking with other databases (e.g. census data)
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allowed inclusion of a minimum number of socio-
demographic variables. Additionally, available statistics
about healthcare resources per capita were available and
linked to the regions of residence in all countries. Details
on variable data sources for each country are given in
Table S1 (see Additional file 1), and data on UNAIDS
prevalence estimates and ART coverage for advanced in-
fection given in S2.
Measures
The place of death was derived from the death certificate
and included the following categories: “home”, “hos-
pital”, “nursing home/care home” and “hospice facility”
in all countries except for Mexico, where nursing home
is not a recorded category as there are very few nursing
home deaths, and hospice was only recorded in
Netherlands, UK and USA.
As independent variables we included individual socio-
demographic variables (age, sex), the clinical variable of
cause of death (dying as a result of HIV/AIDS, rather
than dying with HIV/AIDS) and residential characteris-
tics and healthcare supply measures that have been
identified as relevant in the literature on place of death
of people with cancer [25]. Marital status was not used
as a variable in this analysis due to the high prevalence
of HIV among men who have sex with men and the rare
legal provision for same sex marriage during the time
period under analysis. The codes of the municipality/
local authority of residence were matched with available
data about urbanization level and healthcare supply. The
healthcare supply data included the number of hospital
beds/10,000 inhabitants, the number of GPs/10,000
inhabitants and the number of long-term care beds/1000
inhabitants aged 65 years or over, each per region of
residence of the deceased. For reasons of data protection,
in some countries the individual’s region of residence
could not be obtained. For these countries, we used the
nationally aggregated measure of healthcare supply.
Statistical analysis
The analyses for objective i (i.e. to describe the number
of HIV-related deaths and the demographics for these
deaths, and these deaths as a proportion of total deaths),
were conducted through descriptive analysis for each
country separately.
For objective ii (i.e. to describe the place of death) and
objective iii (i.e. to compare place of death to those who
died from cancer), we conducted descriptive analysis by
country and place of death. We then calculated the risk
ratios (relative risks) by comparing the percentages for
HIV with the age-standardized percentages for cancer,
using direct standardization by applying the age distribu-
tion of the HIV deaths in each country to the cancer
deaths. Age strata used for the standardization were as
follows: 0–49, 50–59, 60–69, 70–79, 80–89, 90+. We
selected cancer as the comparison group as it has been
the diagnostic group that has the greatest coverage of
palliative and end-of-life care. [26]
For objective iv (i.e. to determine whether there are
any predictors of home death, independent variables of
patient and health service characteristics) a parsimoni-
ous model was constructed. We selected the relevant
variables for each country with stepwise backward
variable selection into a logistic regression model. Only
covariates with p < 0.05 were retained in the final model
using the backward conditional procedure. We aimed
Table 1 Deaths from HIV and healthcare supply density in 2008a in 11 countries
Country Abbreviations Total number
of deaths
Deaths from HIV age Urbanization
N (proportion per
1000 deaths)
% male % 0–49 % 50–69 % 70+ % living in core city / very
strongly urbanized municipalityb
France FR 541,135 688 (1.3) 74.3 61.6 30.7 7.7 52.9
Italy IT 578,192 1586 (2.7) 78.4 66.5 29.7 3.8 56.2
Spain (Andalusia)a ES 57,380 188 (3.3) 84.6 76.1 21.8 2.1 68.6
Belgium BE 102,924 50 (0.5) 70.0 64.0 24.0 12.0 80.0
The Netherlands NL 135,136 53 (0.4) 73.6 56.6 37.7 5.7 81.1
Sweden SE 91,471 18 (0.2) 72.2 22.2 77.8 0.0 93.3
England & Wales UK 507,829 242 (0,5) 66.5 71.9 23.1 5.0 95.0
Canada CA 182,134 319 (1.8) 77.1 65.2 30.7 4.1 88.7
United Statesa US 2,428,342 11,332 (4.7) 71.7 63.0 34.6 2.4 /
Mexico MX 528,093 5149 (9.8) 81.7 84.2 14.6 1.2 /
Korea KR 247,757 99 (0.4) 89.9 60.6 31.3 8.1 28.3
Total 5,661,536 19,739 (3.5%) 75.0% 69.1% 28.5% 2.5% /
Percentages may not add up to total due to rounding
aReference year is 2007 in USA and 2010 in Spain;
bin Sweden and Canada, only urban and rural are distinguished
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for similar regression models across countries, in order
to enhance comparability of the effects between coun-
tries. Statistical analyses were carried out using IBM
SPSS version 21. Ethical approval was not required as
we studied anonymised death certificate data.
Results
Objective i) A total of 19,739 out of 5,661,536 deaths
were directly attributed to HIV in the 11 included coun-
tries. These deaths accounted for 0.35% of all reported
deaths (Table 1). The highest proportion (per 1000
deaths) of HIV-related deaths was in Mexico (9.8‰),
and the lowest in Sweden (0.2‰). The majority of deaths
were among men (75%), and those aged <50 (69.1%).
Objective ii) Hospital was the most common place of
HIV-related death in all countries (ranging from 56.6%
in the Netherlands to 90.9% in South Korea) (see
Table 2). The least common places of HIV-related death
were a hospice facility (range 3.3%–5.7%), nursing home
(0%–17.6%) and home (range 5.9%–26.3%).
Objective iii) After age-standardization, the relative
risks indicate that people with HIV were less likely to
die at home and more likely to die in hospitals com-
pared with cancer patients (except in Korea); and in
most countries (when reported) were also more likely to
die in a nursing home. After age-standardization, people
with HIV were considerably less likely than cancer
patients to die in a hospice facility in UK, but slightly
more likely in the USA.
Objective iv) The multivariable regression analyses
revealed that for HIV-related deaths, males were more
likely to die at home in UK, USA, Canada and Mexico
(Table 3). Controlling for other confounders, we found
no significant association with age. Educational attain-
ment was associated with home death in Mexico and
Spain; where those with higher education more likely to
die in hospital. Persons with HIV living in more rural
areas were less likely to die at home in Italy, but more
likely in Spain compared to those living in urban areas.
Living in a region with a higher number of hospital beds
reduced the chances of dying at home in Italy and
Mexico, and living in an area with a higher number of
general practitioners increased the chances of dying
at home in the UK and Mexico (but reduced them in
the USA).
Discussion
This study found that the majority of people who died
from HIV-related causes died in hospital (56.6–90.9%).
After age standardisation, this rate is higher than for
people who died from conditions indicative of palliative
care need (i.e. cancer, renal failure, heart failure, liver
failure, COPD, Alzheimer’s, Parkinson’s, Motor Neurone
Disease, Huntingdon’s; 25–85%).
Table 2 The place of death of HIV vs cancer deaths in 14 countries during 2008
Place of death FR IT ES BE NL SE UKa CA US MX KR
Number of
deaths
688 1586 188 50 53 18 242 319 11,332 5149 99
% % % % % % % % % % %
HIV Home 15.8 9.2 9.6 18.0 15.1 5.9 12.0 12.9 14.9 26.3 9.1
Hospital 79.9 84 85.1 76.0 56.6 76.5 78.1 73 62.8 71 90.9
Nursing home 0.9 3.5 5.3 2.0 17.0 17.6 4.5 6.3 12.1 /b 0
Hospice facility /b /b /b /b 7.5 /b 3.3 /b 5.7 /b /b
Others 3.3 3.4 0 4.0 3.8 0 2.1 7.8 4.6 2.8 0
Cancer (age-standardized) Home 16.1 40.9 19.5 33.5 56.1 24.5 28.1 18.0 38.1 45.5 6.5
Hospital 79.6 54.2 79.6 64.0 28.8 63.4 42.1 71.2 43.1 51.9 92.7
Nursing home 1.3 1.6 1.0 1.8 7.6 10.8 2.2 5.9 7.5 /b 0.6
Hospice facility /b /b /b /b 6.1 /b 25.3 /b 5.3 /b /b
Others 3.0 3.3 0.1 0.8 1.5 1.4 1.8 4.8 5.7 2.6 0.2
Relative Risks: (HIV vs Age-standardized percentages for
cancer)
Home 0.98 0.22 0.49 0.54 0.27 0.24 0.43 0.72 0.39 0.58 1.39
Hospital 1.00 1.55 1.07 1.19 1.97 1.21 1.85 1.03 1.45 1.37 0.98
Nursing home 0.71 2.22 5.49 1.13 2.23 1.63 2.03 1.06 1.61 /b /b
Hospice facility /b /b /b /b 1.23 /b 0.13 1.08 /b /b
Others 1.09 1.03 0.00 5.18 0.50 0.00 1.00 1.63 0.81 1.06 0.00
aEngland and Wales
bCategory not available on the death certificate data
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The higher proportion of hospital deaths for HIV-
related causes may be due to the disproportionate
number of men who have sex with men affected by HIV,
who report poor communication by clinicians at end of
life and disenfranchisement of their significant others
[27, 28]. It is also possible that the trajectory to death is
less predictable for people with HIV, which may trigger
hospital admissions for potentially life-extending inter-
ventions compared to cancer patients [29]. It may also
be partly explained by the admission and initiation of
ART in hospital for people with late presentation of
HIV, attempting new lines of therapy when a treatment
regimen fails, or the complexity of prognostication for
those who face clinical uncertainty. Also, as persons
dying from HIV tend to be younger than those dying of
other conditions (i.e. dementia [30], Parkinsons [31]
Cancer [17] and other terminal conditions) there may be
reluctance on the part of clinicians to discuss the end of
life and options for place of death. However, we ob-
served that even after age standardization, people dying
of cancer in all countries except South Korea were more
likely to die at home than those dying of HIV. That
people dying of cancer are more able to die at home sug-
gests they are potentially more able to receive formal
and informal care in the home, which together enable
home death [25]. This reflects the origins and persisting
cancer focus of palliative care. We also note that people
dying with HIV in the UK did not die in hospice facil-
ities as often as those in the USA. HIV-related deaths in
the UK were considerably less likely than cancer deaths
to occur in a hospice facility. However, HIV and cancer
deaths in the USA were more or less equally likely to
occur in a hospice facility. This observation may reflect
a specifically UK historical context, as the UK developed
HIV hospice care outside of existing hospices [32], but
HIV-specific hospices have now closed, leaving little ex-
perience of HIV care among mainstream hospice
providers.
The use of death certificate data has the major advantage
of providing population-level data that are not subject to
potential bias inherent to sampling and that are cross-
nationally comparable, as the procedure for registering
deaths is similar across countries. Limitations of the present
data are related to the type of information collected in the
death certificate as it is not possible to ascertain preference
for place of death, compare preferences among countries,
or to infer how much time is spent in different care settings
prior to death. The validity of the underlying cause of death
as recorded on the death certificate has been contested
[33], although the use of aggregated cause of death categor-
ies has most likely mitigated the risk of misclassification.
However, HIV is likely underreported as the underlying
Table 3 Multivariable logistic regression models per country of factors associated with home death vs other (odds ratios and
95% Cis)
FR IT ES BE NL SE UK CA US MX KR
Sex
male (vs female) ns ns ns ns ns ns 3.59 (1.19–10.78) 3.10 (1.07–.01) 1.18 (1.05–.33) 1.23 (1.04–.46) ns
Age
0–49 ns ns ns ns ns ns ns ns ns ns ns
50–59 ns ns ns ns ns ns ns ns ns ns ns
60 and older ns ns ns ns ns ns ns ns ns ns ns
Educational attainment
primary or less ns ns Ref cat ns NA ns NA NA ns Ref cat ns
lower secondary ns ns 0.31 (0.08–1.23) ns NA ns NA NA ns 0.59 (0.45–0.77) NA
higher secondary ns ns 0.24 (0.05–1.05) ns NA ns NA NA ns 0.61 (0.51–0.72) ns
higher ns ns / ns NA ns NA NA ns 0.45 (0.37–0.53) ns
Urbanization
strong ns Ref cat Ref cat ns ns ns ns ns NA NA ns
average ns 0.31 (0.13–0.73) 1.22 (0.35–4.24) ns ns ns ns ns NA NA ns
rural ns 0.57 (0.23–1.42) 21.09 (1.55–286.90) ns ns ns ns ns NA NA ns
LTC beds per
1000 65plus
ns ns ns ns ns ns ns ns 0.99 (0.99–0.999) ns NA
Hospital beds
per 10.000
1.03 (1.01–1.06) 0.88 (0.80–0.96) ns ns ns ns ns ns ns 0.70 (0.64–0.75) NA
GPs per 10.000 ns ns ns ns ns ns 4.25 (1.29–13.98) ns 0.93 (0.91–0.95) 1.20 (1.16–1.25) NA
Abbreviations: Ns not significant in the logistic regression model and therefore omitted in the final model, NA not available, Ref cat reference category, NA not
available in database (i.e. there are no long term care beds in Mexico)
There is no separate category lower secondary education for educational attainment in Korea. No regional data on hospital beds, LTC beds and GPs were
available for Korea
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cause of death [34]. We also acknowledge that the data
source only allow us to identify people dying from, rather
than with, HIV infection. Information on household
characteristics and social support may have been a useful
variable in our analysis. The variable that measured number
of GPs/10,000 inhabitants is a useful measure of primary
care coverage, but GP involvement in HIV care may vary
between countries. For example, in the USA it is uncom-
mon for HIV to be managed in primary care settings.
Although studies have demonstrated a preference
among dying adults to die at home, the available data on
these preferences has not been specific to preferences
among people living with, or dying from, HIV. Evidence
is not available on preference for place of death among
people living with HIV, how this varies between coun-
tries, or how much time is spent at home prior to death.
These should be priority areas of investigation.
It is important that policy and service configuration
enable high quality end-of-life care in contexts of both
clinical uncertainty and unavoidable death. Policy,
funding, education and training are essential Govern-
mental responsibilities in light of the World Health
Assembly’s resolution on palliative care [35]. While we
should not presume that those who die in hospital do
not receive palliative care, evidence found that in France
less than half of hospitalized patients in need of
palliative care at the end of life actually received
palliative care during their admission [36]. The barriers
to palliative care for people with HIV have been well
described, and include specific disease-related, clinician-
related and service-related factors [37].
Conclusions
People dying from HIV were, in all studied countries,
most likely to die in hospital as compared to people
dying of cancer. This indicates a particular challenge to
provide high quality end-of-life care for those facing
HIV-related death. Not enough is known about what is
done clinically in hospitals to achieve a “good death” for
people with HIV. Arguably, this lack of evidence on the
quality of death also exists for deaths in nursing homes,
hospices, or other places, notably the home. Except in
Mexico, we found that less than a fifth of persons with
HIV died at home. Local policy is likely to be highly
influential, for example in Korea there are legal difficul-
ties in providing medical services outside of hospital
settings. This variability is also reflected in state and
national laws on advance care plans, living wills and
other relevant mechanisms. There is within-country
variability (e.g. by State in the USA) and also between-
country (for example in Germany home palliative care is
a legal right; in the UK individuals have a legal right to
appoint a proxy or make an advance directive) Further
research is needed to determine end-of-life care
preferences regarding care setting among people with
HIV, on place of care in the last months of life, and the
reasons why they do not spend their final hours or days
at home. The availability of death registries in low
income countries is also a future priority, so that those
countries with poorest ART coverage can also study
place of death. With increasing comorbidity among
people ageing with HIV, it is essential that end-of-life
care preferences are established, and that plans are made
and carried out for those who prefer to die at home or
in a hospice, or a hospital. In this study we have identi-
fied a high proportion of hospital deaths, and inequity in
place of death. Policy makers must ensure that initiatives
to achieve home death do not discriminate between
conditions. Clinicians must ensure that while they
encourage patients to “hope for the best”, they must also
enable them to “plan for the worst”, and ensure that
home death can be achieved irrespective of diagnosis.
This new knowledge highlights the importance of ensur-
ing a “good death” for people with HIV, alongside efforts
to optimise treatment.
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